<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35552562</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1932-6203</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>17</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
            </PubDate>
          </JournalIssue>
          <Title>PloS one</Title>
          <ISOAbbreviation>PLoS One</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Prognostic value of upper respiratory tract microbes in children presenting to primary care with respiratory infections: A prospective cohort study.</ArticleTitle>
        <Pagination>
          <StartPage>e0268131</StartPage>
          <MedlinePgn>e0268131</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e0268131</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0268131</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The association between upper respiratory tract microbial positivity and illness prognosis in children is unclear. This impedes clinical decision-making and means the utility of upper respiratory tract microbial point-of-care tests remains unknown. We investigated for relationships between pharyngeal microbes and symptom severity in children with suspected respiratory tract infection (RTI).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Baseline characteristics and pharyngeal swabs were collected from 2,296 children presenting to 58 general practices in Bristol, UK with acute cough and suspected RTI between 2011-2013. Post-consultation, parents recorded the severity of six RTI symptoms on a 0-6 scale daily for ≤28 days. We used multivariable hurdle regression, adjusting for clinical characteristics, antibiotics and other microbes, to investigate associations between respiratory microbes and mean symptom severity on days 2-4 post-presentation.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, 1,317 (57%) children with complete baseline, microbiological and symptom data were included. Baseline characteristics were similar in included participants and those lacking microbiological data. At least one virus was detected in 869 (66%) children, and at least one bacterium in 783 (60%). Compared to children with no virus detected (mean symptom severity score 1.52), adjusted mean symptom severity was 0.26 points higher in those testing positive for at least one virus (95% CI 0.15 to 0.38, p&lt;0.001); and was also higher in those with detected Influenza B (0.44, 0.15 to 0.72, p = 0.003); RSV (0.41, 0.20 to 0.60, p&lt;0.001); and Influenza A (0.25, -0.01 to 0.51, p = 0.059). Children positive for Enterovirus had a lower adjusted mean symptom severity (-0.24, -0.43 to -0.05, p = 0.013). Children with detected Bordetella pertussis (0.40, 0.00 to 0.79, p = 0.049) and those with detected Moraxella catarrhalis (-0.76, -1.06 to -0.45, p&lt;0.001) respectively had higher and lower mean symptom severity compared to children without these bacteria.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is a potential role for upper respiratory tract microbiological point-of-care tests in determining the prognosis of childhood RTIs.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>McGeoch</LastName>
            <ForeName>Luke J</ForeName>
            <Initials>LJ</Initials>
            <Identifier Source="ORCID">0000-0002-1109-0238</Identifier>
            <AffiliationInfo>
              <Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thornton</LastName>
            <ForeName>Hannah V</ForeName>
            <Initials>HV</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Blair</LastName>
            <ForeName>Peter S</ForeName>
            <Initials>PS</Initials>
            <AffiliationInfo>
              <Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Bristol Randomised Trials Collaboration, Bristol Trials Centre, University of Bristol, Bristol, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Christensen</LastName>
            <ForeName>Hannah</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>NIHR Health Protection Research Unit in Behavioural Science and Evaluation, Bristol Medical School, University of Bristol, Bristol, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Turner</LastName>
            <ForeName>Nicholas L</ForeName>
            <Initials>NL</Initials>
            <Identifier Source="ORCID">0000-0003-1591-6997</Identifier>
            <AffiliationInfo>
              <Affiliation>Bristol Randomised Trials Collaboration, Bristol Trials Centre, University of Bristol, Bristol, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Muir</LastName>
            <ForeName>Peter</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>South West Regional Laboratory, National Infection Service, Public Health England, Bristol, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vipond</LastName>
            <ForeName>Barry</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>South West Regional Laboratory, National Infection Service, Public Health England, Bristol, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Redmond</LastName>
            <ForeName>Niamh M</ForeName>
            <Initials>NM</Initials>
            <Identifier Source="ORCID">0000-0001-8814-3396</Identifier>
            <AffiliationInfo>
              <Affiliation>Centre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre d'épidémiologie et de recherche en santé des populations (CERPOP), Université Toulouse III-Paul Sabatier, Toulouse, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Turnbull</LastName>
            <ForeName>Sophie</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0001-5259-3168</Identifier>
            <AffiliationInfo>
              <Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hay</LastName>
            <ForeName>Alastair D</ForeName>
            <Initials>AD</Initials>
            <Identifier Source="ORCID">0000-0003-3012-375X</Identifier>
            <AffiliationInfo>
              <Affiliation>Centre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>PLoS One</MedlineTA>
        <NlmUniqueID>101285081</NlmUniqueID>
        <ISSNLinking>1932-6203</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001419" MajorTopicYN="N">Bacteria</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>13</Day>
          <Hour>14</Hour>
          <Minute>24</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35552562</ArticleId>
        <ArticleId IdType="pmc">PMC9098075</ArticleId>
        <ArticleId IdType="doi">10.1371/journal.pone.0268131</ArticleId>
        <ArticleId IdType="pii">PONE-D-21-18918</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Jin X, Ren J, Li R, Gao Y, Zhang H, Li J, et al.. Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019. EClinicalMedicine
2021;37:100986. doi: 10.1016/j.eclinm.2021.100986
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.eclinm.2021.100986</ArticleId>
            <ArticleId IdType="pmc">PMC8343248</ArticleId>
            <ArticleId IdType="pubmed">34386754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Troeger C, Blacker B, Khalil IA, Rao PC, Cao J, Zimsen SRM, et al.. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis
2018;18(11):1191–210. doi: 10.1016/S1473-3099(18)30310-4
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(18)30310-4</ArticleId>
            <ArticleId IdType="pmc">PMC6202443</ArticleId>
            <ArticleId IdType="pubmed">30243584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thornton H V., Turner KME, Harrison S, Hammond A, Hawcroft C, Hay AD. Assessing the potential of upper respiratory tract point-of-care testing: a systematic review of the prognostic significance of upper respiratory tract microbes. Clin Microbiol Infect
2019;25:1339–46. doi: 10.1016/j.cmi.2019.06.024
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmi.2019.06.024</ArticleId>
            <ArticleId IdType="pmc">PMC7129693</ArticleId>
            <ArticleId IdType="pubmed">31254715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith S, Morbey R, de Lusignan S, Pebody RG, Smith GE, Elliot AJ. Investigating regional variation of respiratory infections in a general practice syndromic surveillance system. J Public Health
2021;43(2):e153–60. doi: 10.1093/pubmed/fdaa014
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/pubmed/fdaa014</ArticleId>
            <ArticleId IdType="pubmed">32009178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jankauskaite L, Oostenbrink R. Childhood lower respiratory tract infections: more evidence to do less. Lancet. 2021;398(10309):1383–4. doi: 10.1016/S0140-6736(21)01955-3
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(21)01955-3</ArticleId>
            <ArticleId IdType="pubmed">34562390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thompson M, Vodicka TA, Blair PS, Buckley DI, Heneghan C, Hay AD. Duration of symptoms of respiratory tract infections in children: systematic review. BMJ
2013;347:f7027. doi: 10.1136/bmj.f7027
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.f7027</ArticleId>
            <ArticleId IdType="pmc">PMC3898587</ArticleId>
            <ArticleId IdType="pubmed">24335668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hawker JI, Smith S, Smith GE, Morbey R, Johnson AP, Fleming DM, et al.. Trends in antibiotic prescribing in primary care for clinical syndromes subject to national recommendations to reduce antibiotic resistance, UK 1995–2011: Analysis of a large database of primary care consultations. J Antimicrob Chemother
2014;69:3423–30. doi: 10.1093/jac/dku291
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dku291</ArticleId>
            <ArticleId IdType="pubmed">25091508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smieszek T, Pouwels KB, Dolk FCK, Smith DRM, Hopkins S, Sharland M, et al.. Potential for reducing inappropriate antibiotic prescribing in English primary care. J Antimicrob Chemother
2018;73:ii36–43. doi: 10.1093/jac/dkx500
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkx500</ArticleId>
            <ArticleId IdType="pmc">PMC5890667</ArticleId>
            <ArticleId IdType="pubmed">29490058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: Systematic review and meta-analysis. BMJ
2010;340:1120. doi: 10.1136/bmj.c2096
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.c2096</ArticleId>
            <ArticleId IdType="pubmed">20483949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayward G, Thompson M, Hay AD. What factors influence prognosis in children with acute cough and respiratory tract infection in primary care? BMJ
2012;345(7876). doi: 10.1136/bmj.e6212
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.e6212</ArticleId>
            <ArticleId IdType="pubmed">22996938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thornton H V., Hay AD, Redmond NM, Turnbull SL, Christensen H, Peters TJ, et al.. Throat swabs in children with respiratory tract infection: Associations with clinical presentation and potential targets for point-of-care testing. Fam Pract
2017;34(4):407–15. doi: 10.1093/fampra/cmw136
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/fampra/cmw136</ArticleId>
            <ArticleId IdType="pmc">PMC7108458</ArticleId>
            <ArticleId IdType="pubmed">28334924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khalid TY, Duncan LJ, Thornton H V, Lasseter G, Muir P, Toney ZA, et al.. Novel multi-virus rapid respiratory microbiological point-of-care testing in primary care: a mixed-methods feasibility evaluation. Fam Pract
2021;cmab002. doi: 10.1093/fampra/cmab002
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/fampra/cmab002</ArticleId>
            <ArticleId IdType="pubmed">33684208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Neill. Tackling drug-resistant infections globally: final report and recommendations. 2016. Available from: https://amr-review.org/Publications.html.</Citation>
        </Reference>
        <Reference>
          <Citation>Redmond NM, Davies R, Christensen H, Blair PS, Lovering AM, Leeming JP, et al.. The TARGET cohort study protocol: A prospective primary care cohort study to derive and validate a clinical prediction rule to improve the targeting of antibiotics in children with respiratory tract illnesses. BMC Health Serv Res
2013;13:322. doi: 10.1186/1472-6963-13-322
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1472-6963-13-322</ArticleId>
            <ArticleId IdType="pmc">PMC3765099</ArticleId>
            <ArticleId IdType="pubmed">23958109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hay AD, Redmond NM, Turnbull S, Christensen H, Thornton H, Little P, et al.. Development and internal validation of a clinical rule to improve antibiotic use in children presenting to primary care with acute respiratory tract infection and cough: a prognostic cohort study. Lancet Respir Med
2016;4:902–10. doi: 10.1016/S2213-2600(16)30223-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2213-2600(16)30223-5</ArticleId>
            <ArticleId IdType="pmc">PMC5080970</ArticleId>
            <ArticleId IdType="pubmed">27594440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ordóñez-Mena JM, Fanshawe TR, Butler CC, Mant D, Longhurst D, Muir P, et al.. Relationship between microbiology of throat swab and clinical course among primary care patients with acute cough: a prospective cohort study. Fam Pract
2019;37:332–9. doi: 10.1093/fampra/cmz093
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/fampra/cmz093</ArticleId>
            <ArticleId IdType="pmc">PMC7108489</ArticleId>
            <ArticleId IdType="pubmed">31844897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hay AD, Little P, Harnden A, Thompson M, Wang K, Kendrick D, et al.. Effect of oral prednisolone on symptom duration and severity in nonasthmatic adults with acute lower respiratory tract infection: A randomized clinical trial. J Am Med Assoc
2017;318:721–30. doi: 10.1001/jama.2017.10572
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2017.10572</ArticleId>
            <ArticleId IdType="pmc">PMC5817483</ArticleId>
            <ArticleId IdType="pubmed">28829884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wensaas KA, Heron J, Redmond N, Turnbull S, Christensen H, Thornton H, et al.. Post-consultation illness trajectories in children with acute cough and respiratory tract infection: Prospective cohort study. Fam Pract
2018;35:676–83. doi: 10.1093/fampra/cmy021
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/fampra/cmy021</ArticleId>
            <ArticleId IdType="pmc">PMC6290772</ArticleId>
            <ArticleId IdType="pubmed">29897430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watson L, Little P, Moore M, Warner G, Williamson I. Validation study of a diary for use in acute lower respiratory tract infection. Fam Pract
2001;18:553–4. doi: 10.1093/fampra/18.5.553
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/fampra/18.5.553</ArticleId>
            <ArticleId IdType="pubmed">11604383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hay AD, Wilson A, Fahey T, Peters TJ. The duration of acute cough in pre-school children presenting to primary care: A prospective cohort study. Fam Pract
2003;20:696–705. doi: 10.1093/fampra/cmg613
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/fampra/cmg613</ArticleId>
            <ArticleId IdType="pubmed">14701895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cragg JG. Some Statistical Models for Limited Dependent Variables with Application to the Demand for Durable Goods. Econometrica
1971;39:829. doi: 10.2307/1909582</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2307/1909582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Specification Mullahy J. and testing of some modified count data models. J Econom
1986;33:341–65. doi: 10.1016/0304-4076(86)90002-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0304-4076(86)90002-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>StataCorp. 2019. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC.</Citation>
        </Reference>
        <Reference>
          <Citation>Vos LM, Bruyndonckx R, Zuithoff NPA, Little P, Oosterheert JJ, Broekhuizen BDL, et al.. Lower respiratory tract infection in the community: associations between viral aetiology and illness course. Clin Microbiol Infect
2021;27:96–104. doi: 10.1016/j.cmi.2020.03.023
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmi.2020.03.023</ArticleId>
            <ArticleId IdType="pmc">PMC7118666</ArticleId>
            <ArticleId IdType="pubmed">32244051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harnden A, Grant C, Harrison T, Perera R, Brueggemann AB, Mayon-White R, et al.. Whooping cough in school age children with persistent cough: prospective cohort study in primary care. BMJ
2006;333(7560):174. doi: 10.1136/bmj.38870.655405.AE
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.38870.655405.AE</ArticleId>
            <ArticleId IdType="pmc">PMC1513463</ArticleId>
            <ArticleId IdType="pubmed">16829538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bruning AHL, de Kruijf WB, van Weert HCPM, Willems WLM, de Jong MD, Pajkrt D, et al.. Diagnostic performance and clinical feasibility of a point-of-care test for respiratory viral infections in primary health care. Fam Pract
2017;34(5):558–63. doi: 10.1093/fampra/cmx019
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/fampra/cmx019</ArticleId>
            <ArticleId IdType="pmc">PMC7108454</ArticleId>
            <ArticleId IdType="pubmed">28369370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Lusignan S, Hoang U, Liyanage H, Tripathy M, Yonova I, Byford R, et al.. Integrating molecular point-of-care testing for influenza into primary care: a mixed-methods feasibility study. Br J Gen Pract
2020;70(697):e555–62. doi: 10.3399/bjgp20X710897
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3399/bjgp20X710897</ArticleId>
            <ArticleId IdType="pmc">PMC7363279</ArticleId>
            <ArticleId IdType="pubmed">32661013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lingervelder D, Koffijberg H, Kusters R, IJzerman MJ. Point‐of‐care testing in primary care: A systematic review on implementation aspects addressed in test evaluations. Int J Clin Pract
2019;73(10). doi: 10.1111/ijcp.13392
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ijcp.13392</ArticleId>
            <ArticleId IdType="pmc">PMC6790572</ArticleId>
            <ArticleId IdType="pubmed">31313873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, et al.. Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection. Cochrane Database Syst Rev
2021; 8(8):CD013705. doi: 10.1002/14651858.CD013705.pub2
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD013705.pub2</ArticleId>
            <ArticleId IdType="pmc">PMC8078597</ArticleId>
            <ArticleId IdType="pubmed">33760236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carlton HC, Savović J, Dawson S, Mitchelmore PJ, Elwenspoek MMC. Novel point-of-care biomarker combination tests to differentiate acute bacterial from viral respiratory tract infections to guide antibiotic prescribing: a systematic review. Clin Microbiol Infect. 2021;27(8):1096–108. doi: 10.1016/j.cmi.2021.05.018
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmi.2021.05.018</ArticleId>
            <ArticleId IdType="pubmed">34015531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cooke J, Llor C, Hopstaken R, Dryden M, Butler C. Respiratory tract infections (RTIs) in primary care: narrative review of C reactive protein (CRP) point-of-care testing (POCT) and antibacterial use in patients who present with symptoms of RTI Respiratory infection. BMJ Open Resp Res
2020;7:624. doi: 10.1136/bmjresp-2020-000624
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmjresp-2020-000624</ArticleId>
            <ArticleId IdType="pmc">PMC7476490</ArticleId>
            <ArticleId IdType="pubmed">32895246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thornton H V., Khalid T, Hay AD. Point-of-care testing for respiratory infections during and after COVID-19. Br J Gen Pract
2020;70(701):574–5. doi: 10.3399/bjgp20X713561
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3399/bjgp20X713561</ArticleId>
            <ArticleId IdType="pmc">PMC7679147</ArticleId>
            <ArticleId IdType="pubmed">33199292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stuart B, Hounkpatin H, Becque T, Yao G, Zhu S, Alonso-Coello P, et al.. Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis. BMJ
2021;373:n808. doi: 10.1136/bmj.n808
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.n808</ArticleId>
            <ArticleId IdType="pmc">PMC8080136</ArticleId>
            <ArticleId IdType="pubmed">33910882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loens K, Van Heirstraeten L, Malhotra-Kumar S, Goossens H, Ieven M. Optimal sampling sites and methods for detection of pathogen possibly causing community-acquired lower respiratory tract infections. J Clin Microbiol
2009;47:21–31. doi: 10.1128/JCM.02037-08
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.02037-08</ArticleId>
            <ArticleId IdType="pmc">PMC2620840</ArticleId>
            <ArticleId IdType="pubmed">19020070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hay AD, Heron J, Ness A. The prevalence of symptoms and consultations in pre-school children in the Avon Longitudinal Study of Parents and Children (ALSPAC): A prospective cohort study. Fam Pract
2005;22:367–74. doi: 10.1093/fampra/cmi035
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/fampra/cmi035</ArticleId>
            <ArticleId IdType="pubmed">15897210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hay AD, Anderson E, Ingle S, Beck C, Hollingworth W. Respiratory tract infections in children in the community: Prospective online inception cohort study. Ann Fam Med
2019;17:14–22. doi: 10.1370/afm.2327
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1370/afm.2327</ArticleId>
            <ArticleId IdType="pmc">PMC6342588</ArticleId>
            <ArticleId IdType="pubmed">30670390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Butler CC, van der Velden AW, Bongard E, Saville BR, Holmes J, Coenen S, et al.. Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial. Lancet
2020;395:42–52. doi: 10.1016/S0140-6736(19)32982-4
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(19)32982-4</ArticleId>
            <ArticleId IdType="pubmed">31839279</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
